12.07.2015 Views

Haematologica 2004;89: supplement no. 6 - Supplements ...

Haematologica 2004;89: supplement no. 6 - Supplements ...

Haematologica 2004;89: supplement no. 6 - Supplements ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

VIII Congress of the Italian Society of Experimental Hematology, Pavia, September 14-16, <strong>2004</strong>107PO-073EARLY AND LATE RECOMBINATIONS AT THE IMMUNOGLOBULINκ LIGHT CHAIN LOCUS OF MUTLIPLE MYELOMA: EVIDENCE OFRAG ACTIVITY IN GERMINAL CENTERSPerfetti V,° Colli Vignarelli M,° Palladini G,°Navazza V,° Giachi<strong>no</strong> C, # Merlini G*°Department of Internal Medicine, Internal Medicineand Medical Oncology, and the *Biotech<strong>no</strong>logyResearch Laboratories, IRCCS Policlinico S. Matteo,Department of Biochemistry, University of Pavia, and#IRCCS Fondazione Maugeri, Pavia, ItalyB cells may undergo sequential rearrangements atthe light chain loci, despite already expressing lightchain receptors. This phe<strong>no</strong>me<strong>no</strong>n, k<strong>no</strong>wn as secondaryrearrangement, may occur during differentiationin the bone marrow (receptor editing) and in theperiphery, at some point of the germinal center reaction(receptor revision). To study light chain recombinationsthat preceded the development of a marrowplasma cell we used multiple myeloma as a singlecell-model and, taking advantage of the fact thatIg light chains usually rearrange before Ig ones, weused PCR to analyze the Ig locus of twenty-nine Igmyeloma cases. The results indicated that all Ig alleleswere inactivated via rearrangement of the κdeleting element, more frequently to a V segment(69%) than to the intronic recombination signalsequence (31%). Eighteen alleles (16 myelomaclones) had previous V-J attempts, and these revealedincreased utilization of distal V and J gene segments(J 56%), a marker of multiple sequential rearrangement.In-frame V-J rearrangements were found inapproximately 1/3 of available joints (5/18, with oneinvolving a V pseudogene), each one in differentmyeloma clones: 3 were identical to germline (i. e.compatible either with editing in the bone marrow orwith revision before the onset of somatic changes),while 1 had several nucleotide substitutions indicatinginactivation after the germinal center reactionhad been initiated. The present findings have relevancefor light chain genetics and support the viewthat developing B-cells may undergo both early andlate recombinations at the light chain locus. Sustainedactivity of recombination-activating genesmay contribute to immu<strong>no</strong>globulin translocations inB-cell neoplasias.PO-074CHARACTERIZATION OF ONCOGENE DYSREGULATION IN MULTI-PLE MYELOMA BY COMBINED FISH AND DNA MICROARRAYANALYSESFabris S,* Agnelli l,* Mattioli M,* Baldini l,*Ronchetti D,* Morabito F, + Verdelli D,* Nobili l,*Intini D,* Callea V, + Stelita<strong>no</strong> C, + Maiolo AT,*Lombardi L,* Neri A**Laboratorio di Ematologia Sperimentale e GeneticaMolecolare, U. O. Ematologia 1, Dipartimento diScienze Mediche, Università degli Studi di Mila<strong>no</strong>,Ospedale Maggiore IRCCS, Milan; + Divisione di Ematologiae Centro Trapianto di Midollo, Azienda Ospedaliera“Bianchi-Melacrinò-Morelli”, Reggio Calabria,ItalyMultiple myeloma (MM) is a neoplastic proliferatio<strong>no</strong>f plasma cells characterized by a marked biologicaland clinical heterogeneity. Dysregulation ofdistinct putative oncogenes, as a result of chromosomaltranslocations involving the IGH locus at14q32, occurs frequently in MM. Such oncogenicevents are thought to be linked with the transformationand clonal evolution of malignant plasmacells and may have a significance in the definition ofdifferent entities of the disease. In the present study,the expression profiles of FGFR3/MMSET, CCND1,CCND3, MAF and MAFB, involved respectively in thet(4;14)(p16.3;q32), t(11;14)(q13;q32), t(6;14)(p21;q32), t(16;14)(q23;q32), and t(14;20)(q32;q12),were investigated on purified plasma cell populationsfrom 39 MM and 6 plasma cell leukemia (PCL)patients by DNA microarray analysis and comparedwith the presence of translocations as assessed bydual-color FISH or RT-PCR. The t(4;14) was found in6 MM patients, the t(11;14) in 10 patients (9 MMand 1 PCL), the t(6;14) in one MM case, the t(14,16)in three cases (2 MM and 1 PCL), and the t(14;20) i<strong>no</strong>ne PCL. Traslocations were associated with spikedexpression of target genes in all cases. In addition,gene expression profiling allowed to the identificatio<strong>no</strong>f putative chromosomal translocations dysregulatingthe CCND1 (1 MM and 1 PCL) and MAFB (1MM and 1 PCL) without any apparent involvement ofimmu<strong>no</strong>globulin loci. Notably, all of the translocationswere found to be mutually exclusive. Interestingly,marked increased levels of MMSET expressionhave been found in one MM case in which a 4p16.3allele was localized on an unidentified chromosome.Overall, our data support the <strong>no</strong>tion that translocations(either or <strong>no</strong>t involving the IGH locus) representthe mechanism of dysregulation of putative oncogenesprimarily involved in myelomagenesis and suggestthe importance of combined molecular cytogeneticsand gene expression approaches for the detectio<strong>no</strong>f genetic aberrations in MM.haematologica vol. <strong>89</strong>[suppl. n. 6]:september <strong>2004</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!